{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:48:02Z","timestamp":1775224082040,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01194-8","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:21:38Z","timestamp":1772191298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of JIA subtypes, clinical features, treatment patterns, and early outcomes in Palestinian children: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8030-081X","authenticated-orcid":false,"given":"Fawzy M.","family":"Abunejma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1721-0038","authenticated-orcid":false,"given":"Wasef","family":"Alhroub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9786-8529","authenticated-orcid":false,"given":"Ahmad","family":"Fasfoos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Imwas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ghawadreh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"2","key":"1194_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: A systematic review. Joint Bone Spine. 2014;81(2):112\u20137.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"1194_CR2","first-page":"90","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opu \u00d6. Juvenile Idiopathic Arthritis Balk Med J. 2017;34(2):90\u2013101.","journal-title":"Juvenile Idiopathic Arthritis Balk Med J"},{"issue":"2","key":"1194_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pcl.2012.03.014","volume":"59","author":"PJ Gowdie","year":"2012","unstructured":"Gowdie PJ, Tse SML. Juvenile Idiopathic Arthritis. Pediatr Clin North Am. 2012;59(2):301\u201327.","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"1194_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R, et al. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2019;46(2):190\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"1194_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12969-021-00572-8","volume":"19","author":"RM Alzyoud","year":"2021","unstructured":"Alzyoud RM, Alsuweiti MO, Almaaitah HQ, Aladaileh BN, Alnoubani MK, Alwahadneh AM. Juvenile idiopathic arthritis in Jordan: single center experience. Pediatr Rheumatol. 2021;19(1):90.","journal-title":"Pediatr Rheumatol"},{"key":"1194_CR6","first-page":"1","volume":"2016","author":"MH Al-Hemairi","year":"2016","unstructured":"Al-Hemairi MH, Albokhari SM, Muzaffer MA. The Pattern of Juvenile Idiopathic Arthritis in a Single Tertiary Center in Saudi Arabia. Int J Inflamm. 2016;2016:1\u20138.","journal-title":"Int J Inflamm"},{"key":"1194_CR7","doi-asserted-by":"crossref","unstructured":"Dagher R, Assi S. Juvenile idiopathic arthritis: a single center Lebanese study. Pediatr Rheumatol 2014 Sept;12(S1):P179, 1546-0096-12-S1-P179.","DOI":"10.1186\/1546-0096-12-S1-P179"},{"issue":"4","key":"1194_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/acr.24436","volume":"73","author":"SM Al-Mayouf","year":"2021","unstructured":"Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, et al. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group. Arthritis Care Res. 2021;73(4):586\u201392.","journal-title":"Arthritis Care Res"},{"key":"1194_CR9","doi-asserted-by":"crossref","unstructured":"Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O\u2019Neil KM, Zeft AS, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012 June;64(6):2012\u201321.","DOI":"10.1002\/art.34343"},{"issue":"13","key":"1194_CR10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2010.375","volume":"303","author":"D Foell","year":"2010","unstructured":"Foell D. Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial. JAMA. 2010;303(13):1266.","journal-title":"JAMA"},{"issue":"5","key":"1194_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/acr.22477","volume":"67","author":"CY Chang","year":"2015","unstructured":"Chang CY, Meyer RML, Reiff AO. Impact of Medication Withdrawal Method on Flare-Free Survival in Patients with Juvenile Idiopathic Arthritis on Combination Therapy. Arthritis Care Res. 2015;67(5):658\u201366.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"1194_CR12","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"11","key":"1194_CR13","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.21389","volume":"52","author":"CA Wallace","year":"2005","unstructured":"Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(11):3554\u201362.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1194_CR14","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J Rheumatol"},{"issue":"5","key":"1194_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/acr.24858","volume":"74","author":"J Guzman","year":"2022","unstructured":"Guzman J, Petty RE. A Moving Target: Lessons From Long-Term Studies in Juvenile Idiopathic Arthritis. Arthritis Care Res. 2022;74(5):716\u20138.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"1194_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/acr.24857","volume":"74","author":"M Glerup","year":"2022","unstructured":"Glerup M, Arnstad ED, Rypdal V, Peltoniemi S, Aalto K, Rygg M, et al. Changing Patterns in Treatment, Remission Status, and Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis. Arthritis Care Res. 2022;74(5):719\u201327.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1194_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-019-1994-8","volume":"21","author":"E Berthold","year":"2019","unstructured":"Berthold E, M\u00e5nsson B, Kahn R. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. Arthritis Res Ther. 2019;21(1):218.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1194_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12969-019-0363-0","volume":"17","author":"YJ Shih","year":"2019","unstructured":"Shih YJ, Yang YH, Lin CY, Chang CL, Chiang BL. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. Pediatr Rheumatol. 2019;17(1):58.","journal-title":"Pediatr Rheumatol"},{"issue":"10","key":"1194_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/children10101647","volume":"10","author":"S Di Gennaro","year":"2023","unstructured":"Di Gennaro S, Di Matteo G, Stornaiuolo G, Anselmi F, Lastella T, Orlando F, et al. Advances in the Diagnosis and Treatment of Enthesitis-Related Arthritis. Children. 2023;10(10):1647.","journal-title":"Children"},{"issue":"4","key":"1194_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.46497\/ArchRheumatol.2023.10035","volume":"38","author":"Z Rana \u0130\u015fg\u00fcder","year":"2023","unstructured":"Rana \u0130\u015fg\u00fcder Z, K\u0131z\u0131lda\u011f R\u00fcya, Torun T, Ayd\u0131n B, Makay. Erbil \u00dcnsal. Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics? Arch Rheumatol. 2023;38(4):602\u201310.","journal-title":"Arch Rheumatol"},{"issue":"1","key":"1194_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12969-022-00769-5","volume":"20","author":"J Gieling","year":"2022","unstructured":"Gieling J, Van Den Bemt B, Hoppenreijs E, Schatorj\u00e9 E. Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors. Pediatr Rheumatol. 2022;20(1):109.","journal-title":"Pediatr Rheumatol"},{"issue":"9","key":"1194_CR22","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.18203\/2349-3291.ijcp20242337","volume":"11","author":"D Pan","year":"2024","unstructured":"Pan D, Nandi M, Samanta M, Gupta N. Profile of anemia in children with juvenile idiopathic arthritis. Int J Contemp Pediatr. 2024;11(9):1246\u201351.","journal-title":"Int J Contemp Pediatr"},{"key":"1194_CR23","doi-asserted-by":"crossref","unstructured":"Troiani R, La Bella S, Muselli M, D\u2019Egidio M, Sassano G, Di Ludovico A, et al. Serum hepcidin evaluation as a promising biomarker in juvenile idiopathic arthritis. Clin Exp Rheumatol [Internet]. 2024 Jan 19 [cited 2025 Dec 8]; Available from: https:\/\/www.clinexprheumatol.org\/abstract.asp?a=20830.","DOI":"10.55563\/clinexprheumatol\/a51j2e"},{"issue":"04","key":"1194_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4236\/ojra.2021.114019","volume":"11","author":"SM Albokhari","year":"2021","unstructured":"Albokhari SM, Muzaffer M. Anemia in Juvenile Idiopathic Arthritis (JIA) and Other Pediatric Rheumatologic Diseases: A Retrospective Study. Open J Rheumatol Autoimmune Dis. 2021;11(04):188\u2013202.","journal-title":"Open J Rheumatol Autoimmune Dis"},{"issue":"5","key":"1194_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/cells13050442","volume":"13","author":"DM Nicoar\u0103","year":"2024","unstructured":"Nicoar\u0103 DM, Munteanu AI, Scutca AC, Brad GF, Jug\u0103naru I, Bugi MA, et al. Examining the Relationship between Systemic Immune\u2013Inflammation Index and Disease Severity in Juvenile Idiopathic Arthritis. Cells. 2024;13(5):442.","journal-title":"Cells"},{"key":"1194_CR26","doi-asserted-by":"crossref","unstructured":"Storwick JA, Brett AC, Buhler K, Chin A, Schmeling H, Johnson NA, et al. Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2022 June;21(6):103086.","DOI":"10.1016\/j.autrev.2022.103086"},{"key":"1194_CR27","doi-asserted-by":"crossref","unstructured":"Ozdel S, S\u00f6nmez HE, \u00c7a\u011flayan \u015e, Akg\u00fcn \u00d6, Ayd\u0131n T, Baba \u00d6, et al. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience. Pediatr Rheumatol 2023 July 20;21(1):72.","DOI":"10.1186\/s12969-023-00860-5"},{"issue":"1","key":"1194_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/pediatric16010014","volume":"16","author":"HG Hern\u00e1ndez-Huirache","year":"2024","unstructured":"Hern\u00e1ndez-Huirache HG, Armenta-Medina D, Rodea-Montero ER. Clinical, Immunological and Inflammatory Characteristics among Mexican Children with Different Subtypes of Juvenile Idiopathic Arthritis: Exploring the Correlation between Anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF). Pediatr Rep. 2024;16(1):151\u201362.","journal-title":"Pediatr Rep"},{"issue":"1","key":"1194_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12887-024-05032-2","volume":"24","author":"B Jittawattanarat","year":"2024","unstructured":"Jittawattanarat B, Charuvanij S, Tangcheewinsirikul S, Sukharomana M. Prevalence of HLA-B27, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis. BMC Pediatr. 2024;24(1):555.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1194_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12969-024-00969-1","volume":"22","author":"MM Sabounji","year":"2024","unstructured":"Sabounji MM, Ndiaye A, Diallo S. Profile of HLA-B27-positive enthesitis\/spondylitis-related arthritis in Senegal, West Africa. Pediatr Rheumatol. 2024;22(1):31.","journal-title":"Pediatr Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01194-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:57:40Z","timestamp":1775221060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01194-8","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board (IRB) of Hebron University (IRB Registration No. ER.CM.72.2025), and permission to access patient medical records was granted by PRCS Hospital. The IRB also formally waived the requirement for informed consent, as the study was retrospective and used anonymized, de-identified data. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}